Publications by authors named "Morgan McCafferty"

Claim this Profile
C
COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug-Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts.
Scott Guenthner, Wendy McFalda, Pearl Kwong, Kimberly Eads, Morgan McCafferty

Dermatol Ther (Heidelb)ยท October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis